Eurand
Amsterdam
About Eurand
Eurand N.V. (Eurand) is a holding company. The Company is a specialty pharmaceutical company that develops, manufactures and commercializes pharmaceutical and biopharmaceutical products. The Company is commercializing a portfolio of products for cystic fibrosis (CF) and gastrointestinal (GI) patients in the United States. As of December 31, 2009, it had two late-stage product candidates, EUR-1073 (beclomethasone) and EUR-1025 (ondansetron) in development in its own portfolio, as well as a number of other products in development with collaboration partners, including EUR-1000, which is partnered with GlaxoSmithKline (GSK). It has manufacturing and research facilities in the United States, Italy and France.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Ticker: nasdaq:EURX
- Website: eurand.com
- Phone: (800) 678-1605
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/eurand-3435295 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.